E-1899: An Eastern Cooperative Oncology Group Study Comparing Ketoconazole Plus Hydrocortisone with Docetaxel Plus Estramustine for Asymptomatic, Androgen-Independent, Nonmetastatic Prostate Cancer Patients with Rising PSA Levels

Many prostate cancer patients with rising prostate-specific antigen (PSA) levels following radical prostatectomy or radiotherapy receive “early” hormonal therapy, despite its uncertain benefit. When these patients ultimately progress to androgen independence, their management remains controversial,...

Full description

Saved in:
Bibliographic Details
Main Authors: Dreicer, Robert, Carducci, Michael
Format: Artigo
Language:Inglês
Published: MedReviews, LLC 2003
Subjects:
Optimizing Treatment for Advanced Prostate Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1502346/
https://ncbi.nlm.nih.gov/pubmed/16985951
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items